Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: Benralizumab
Study Title: A study to learn more about how benralizumab affects breathing in people with severe asthma that was not well controlled by previous treatment
Thank you!
Thank you to the participants who took part in the clinical study for the study drug benralizumab. You and all the participants helped researchers learn more about if benralizumab can help people with severe asthma that is not well controlled by previous treatment.
AstraZeneca AB sponsored this study and thinks it is important to share the results of the study with the participants and the public. An independent non-profit organization called CISCRP helped prepare this summary of the study results. We hope it helps the participants understand and feel proud of their important role in medical research.
If you participated in the study and have questions about the results, please speak with the doctor or staff at your study site.
What is happening with the study now?
The participants were in the study for up to about 6 months. But, the entire study took about 1 year and 9 months to finish.
The study started in November 2016 and ended in August 2018. The study included 233 participants in 6 countries, including Chile, Germany, Hungary, the Philippines, South Korea, and the United States.
The sponsor reviewed the data collected when the study ended and created a report of the results. This is a summary of that report.